Vital Farms: O'Hayer expects to sell 372,000 shares

The shares are described as founder shares acquired from Vital Farms on November 3, 2012.

Available on EDGAR 11/06/2026 - 05:07 PM EST Accepted by SEC EDGAR 11/06/2026 - 05:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Vital Farms, Inc. is named as issuer in a notice for the expected sale by Matthew O'Hayer, listed as an affiliate and 10% shareholder, of 372,000 common shares through J.P. Morgan Securities LLC. The approximate sale date is November 6, 2026, and the notice states the shares are expected to be sold within three months. The listed aggregate market value is $3,541,440. The shares are identified as founder shares acquired from the issuer on November 3, 2012.

Key Figures

Common shares expected to be sold: 372,000 shares Aggregate market value: $3,541,440 Shares outstanding: 42,936,010 shares

3 metrics

Common shares expected to be sold 372,000 shares Expected sale

Aggregate market value $3,541,440 Securities expected to be sold

Shares outstanding 42,936,010 shares Vital Farms common shares

Key Terms

Rule 144, Affiliate, Founder Shares

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Affiliate regulatory

"Affiliate 10% Shareholder"

Founder Shares financial

"Founder Shares | Issuer"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VITL shares does Matthew O'Hayer expect to sell?

Matthew O'Hayer's notice covers an expected sale of 372,000 common shares, with an aggregate market value of $3,541,440 listed.

When did Matthew O'Hayer acquire the VITL founder shares listed for sale?

The shares are identified as founder shares acquired from the issuer on November 3, 2012.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001025680
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vital Farms, Inc.
SEC File Number	001-39411
Address of Issuer	3601 South Congress Ave, Suite C100 Austin TEXAS 78704
Phone	877-455-3063
Name of Person for Whose Account the Securities are To Be Sold	Matthew O'Hayer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate
Relationship to Issuer	10% Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	372000	3541440	42936010	11/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/03/2012	Founder Shares	Issuer			372000	11/03/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares represented on this filing are shares expected to be sold within 3 months of this filing.
Date of Notice	11/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Matthew O'Hayer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)